The PI3K/mTOR dual inhibitor GSK458 showed inhibitory efficacy against ovarian cancer cell proliferation and tumor growth through induction of cell cycle G1 arrest in nude mice and a PDX model (43). This evidence concerns the gene MTOR and ovarian carcinoma.